The global cell counting devices market
by Product Type (Instruments (Hemocytometer, Flow Cytometer, Spectrophotometer, and Others), Consumables), By End User (Research Institutes, Diagnostic Centers, and Hospitals), and By Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa)
was valued at US$ 5,905.2
million in 2017 and is projected to exhibit a CAGR of 7.8
% over the forecast period (2019–2026), as highlighted in a new report published by .
Key players are focused on developing new products for cell counting, which is expected to propel the global cell counting devices market growth. For instance, in January 2019, DeNovix Inc. launched a product, Cell Drop Automated Cell Counter for analysis of cell culture. It has dual fluorescence and bright-field optics, and also, easy to use analyzer. It includes direct pipette technology, which ensures precise and accurate cell suspension. It does not require any calibration. It is designed with the aim to eliminate the slides and the complex method of hemocytometer.
Moreover, key players also actively involved in participating in conferences and events related to cell counting device. For instance, in February 2019, BioRad Laboratories Inc. participated in Society for Laboratory Automation and Screening 2019 (SLAS), held in Washington D.C., wherein it showcased its product, ZE5 cell analyzer. It consists a robotic arm, which ensures precise and accurate measurements of additions of reagents and also enables easy integration of fluids. It is capable of processing 96 or 384 plates under 60 minutes.
Browse 28 Market Data Tables and 35 Figures spread through 181 Pages and in-depth TOC on Global Cell Counting Devices Market by Product Type (Instruments (Hemocytometer, Flow Cytometer, Spectrophotometer, and Others), By End User (Research Institutes, Diagnostic Centers, and Hospitals) and By Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026
To know the latest trends and insights prevalent in the global cell counting devices market, click the link below:
In 2017, GE Healthcare, a company that designs imaging and monitoring systems entered into a partnership with Guangzhou RiboBio Co., Ltd., a biotechnology company to establish oligonucleotide drug development and manufacturing facility in China. GE healthcare provided all the advanced instruments, which also includes IN Cell Analyzer 6500H, while Guangzhou RiboBio supported the infrastructure and provided with the staff. IN Cell Analyzer 6500H is an imaging system based on IRIS confocal technology. Its features live cell imaging, three dimensional imaging, and higher throughput.
Moreover, in April 2019, Nexcelom Bioscience, a manufacturer of cell counting and characterization products released Cellaca MX. It is an automated cell counter consisting of bright field and fluorescence imaging cytometry. Around 24 samples can be processed in 48 seconds allowing high throughput and high speed. Hence, these factors are expected to drive the global cell counting devices market growth.
Key Takeaways of the Global Cell Counting Devices Market:
- The global cell counting devices market is expected to exhibit a CAGR of 8% over the forecast period (2019–2026), owing to rising prevalence of diseases such as malaria, typhoid, dengue, and other vector-borne diseases
- Product launches by key players are expected to accelerate the global cell counting devices market growth
- Active participation of key players into the cell counting devices market is expected to positively influence the global cell counting devices market growth
- Major players operating in the global cell counting devices market include Paul Marienfeld GmbH & Co. KG, ChemoMetec A/S, BioTek Instruments, Inc., Becton, Dickinson and Company, Tip Biosystems, Corning Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., GE Healthcare, and Thermo Fisher Scientific